Reuters logo
BRIEF-Momenta Pharmaceuticals says U.S. court found its patent for manufacturing LOVENOX "was infringed"
July 21, 2017 / 6:25 PM / 5 months ago

BRIEF-Momenta Pharmaceuticals says U.S. court found its patent for manufacturing LOVENOX "was infringed"

July 21 (Reuters) - Momenta Pharmaceuticals Inc:

* Momenta Pharmaceuticals announces jury verdict in Enoxaparin Sodium Injection patent litigation against Amphastar

* U.S. court issued verdict finding that co’s U.S. patent covering methods for manufacturing of generic LOVENOX “was infringed” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below